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Basic Investigations 
Effects of Shenlian Extracts (খ㦆ᦤপ⠽) on Atherosclerosis by Inhibition 
of the Inflammatory Response 
LI Yu-jie ᴢ⥝⋕, CHEN Ying 䰜乪, YOU Yun ␌ѥ, WENG Xiao-gang 㖕ᇣ߮, YANG Qing ᴼᑚ,  
RUAN Cong-xiao 䰂Ң┛, and ZHU Xiao-xin ᴅᰧᮄ
Objective: Inflammation plays a critical role in atherosclerosis, and this inflammatory reaction is being intensively 
studied. Shenlian Extracts (খ㦆ᦤপ⠽), an active ingredient of Chinese medicinal herbs, is believed to have 
multiple therapeutic and preventive effects against human vascular diseases, including atherosclerosis. Our work 
investigated whether Shenlian Extracts serves as an anti-inflammatory agent during atherogenesis. 
Methods: We established a model of atherosclerosis in rabbits using balloon angioplasty and a high cholesterol diet. 
The effects of Shenlian Extracts on vessel structure and inflammation were assessed by hematoxylin-eosin staining 
of the femoral artery, measurement of inflammation-related factors in serum or vascular tissue, and 
radioimmunoassay. Enzyme linked immunosorbent assays (ELISA), flow cytometry and western blots were also 
performed. 
Results: We show that oral pre-treatment with Shenlian Extracts suppressed the pathological changes associated 
with atherosclerosis and that graded doses of Shenlian Extracts reduced total serum levels of cholesterol (90, 180 
and 360 mg/kg), triglyceride (180 and 360 mg/kg), and LDL-c (90, 180 mg/kg). Various doses of Shenlian Extracts 
reduced serum content of TNF-Į (180 and 360 mg/kg), CRP (90, 180 and 360 mg/kg) and IL-8 (360 mg/kg) 
(P<0.05), but led to no significant changes in IL-1ȕ levels. Treatment with Shenlian Extracts also significantly 
reduced VCAM-1 levels (90 and 360 mg/kg) and IGF-1 levels (90 and 180 mg/kg) in vascular tissue but had no 
significant effect on ICAM-1 and MCP-1 levels. Finally, Shenlian Extracts significantly reduced the abnormal 
expression of CD18 in monocytes in a dose-dependent manner.  
Conclusion: These results suggest that Shenlian Extracts may play a direct role in preventing and treating 
atherogenesis by inhibiting the inflammatory reaction, providing insights into the possible mechanism underlying 
the anti-atherosclerotic actions of Shenlian Extracts. 
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The pathogenesis of atherosclerosis is complex. At 
present, the widely-supported theories explaining 
atherosclerosis are referred to as the ‘injury-response 
theory’ and the ‘inflammatory reaction theory’.1-3
Intervention at key points in the atherosclerosis 
inflammatory response network can interrupt the 
formation of atherosclerosis and reduce the degree of 
injury. 
A large number of epidemiological and clinical studies 
have verified that steroidal and non-steroidal anti- 
inflammatory drugs, antibiotics, Fibrate anti- 
hyperlipidemic drugs and thiazolidinedione medicines, 
5-lipoxygenase inhibitors,4,5 and leukotriene receptor 
antagonists (LTRAs)6,7 can play important roles in 
reducing atherosclerosis formation and stabilizing 
atherosclerosis plaques. It has been suggested that the 
leukotriene-related inflammation pathway will become 
“the important target blocking the development of 
atherosclerosis related inflammation”.8 Shenlian Extracts 
(খ㦆ᦤপ⠽) is a compound of Chinese herbal extracts.
Our previous studies have shown that this compound 
interferes in the early formation of atherosclerosis by 
regulating endothelial relaxation and contraction 
functions as well as secretion, and improves 
hemorheological features in atherosclerotic rats.9,10 Our 
results further suggest that Shenlian Extracts might also 
significantly delay and reduce the severity of disease in 
atherosclerotic rabbits by affecting lipid metabolism.9,10
 In this study, the pharmacological effects of Shenlian 
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Extracts on early and long-term atherosclerosis were 
observed using a rabbit model of atherosclerosis. The 
extent and area of atherosclerosis plaque formation were 
used as an indication of the overall efficacy of the 
treatment. Adhesion factors, cytokines, growth factors, 
and chemotactic factors in Serum or vascular tissue were 
measured to obtain an indication of the severity of the 
inflammatory reaction. 
MATERIALS AND METHODS 
Animals and Drug Administration 
Healthy male New Zealand rabbits weighting 2.2–2.8 kg 
were provided by the Beijing Tongli Laboratory Animal 
Breeding Center (Beijing, China). Each animal was 
housed in a separate cage in a room at temperature 
22±0.5°C. All experiments conformed to the guidelines 
of the Animal Care Committee of the China Academy of 
Chinese Medical Sciences. Animals were grouped 
randomly into six groups of ten animals: a control 
(sham-operated) group, and five atherosclerosis (model) 
groups; one group was treated with distilled water, three 
groups received different doses of Shenlian Extracts (90 
mg/kg, 180 mg/kg, or 360 mg/kg), and one group 
received Simvastatin (10 mg/kg). Each group was 
administered its treatment intragastrically once per day. 
Shenlian Extracts, which contains tanshinone IIa (3%), 
salvianolic acid B (38%), tanshinol (1.6%) and 
andrographolide (20%), was provided by the Chemistry 
Laboratory of the Institute of Chinese Materia Medica, 
China Academy of Chinese Medical Sciences (Beijing, 
China).
Induction of Atherosclerosis 
Our model of atherosclerosis in rabbits was established 
using a combination of balloon angioplasty and high 
cholesterol diet.11,12 
Measurement of Blood Lipoprotein  
Ten weeks after initiation of atherosclerosis and drug 
administration, rabbits were fasted overnight and 
anaesthetized with diethyl ether before blood samples 
were collected directly from the heart chamber. Blood 
samples were collected into plain sample bottles and 
allowed to clot at room temperature for 4 h before they 
were centrifuged using a Uniscope Laboratory 
Centrifuge (Model SM 902B, Surgifriend Medicals, 
England, UK) at 10,000 × g at the same temperature for 
20 min to separate the sera. Blood lipoproteins, including 
total cholesterol (SEKISUI, R1804RIF, R2803RHF), 
triacylglycerols (Prodia Diagnostics, 04142), and high 
density lipoproteins (SEKISUI, R1805RJF, R2807RJF), 
were assayed with a biochemical autoanalyzer (Olympus 
Au640) by the clinical laboratory of Dongzhimen 
Hospital. LDL-c = (TC - (HDL-c + (TG/5)). 
Measurement of CD18 in Peripheral Blood 
Monocytes  
Peripheral blood (0.5 mL) was sampled through the ear 
vein and anticoagulated with EDTA (10%) after 10 
weeks of treatment. The expression of CD18 on 
monocytes (CD14 positive cells) was detected by flow 
cytometry (FCM) and western blot analysis. 
Histopathological Assessment  
After 10 weeks of treatment, all animals were sacrificed. 
A blood vessel (2 cm) between the abdominal aortic 
bifurcation and the femoral artery ligature was harvested 
immediately and fixed with 4% paraformaldehyde, then 
paraffin-embedded and stained with hematoxylin eosin.
Measurement of Correlative Inflammatory Factors 
Blood was sampled to separate serum. Levels of TNF-Į, 
IL-1ȕ, IL-8 were tested by radioimmunoassay (RIA). 
C-reactive protein (CRP) levels were tested by 
immunoturbidimetry (ITM). 
Vessels 1 cm above abdominal aortic bifurcation as well 
as 1 cm between abdominal aortic bifurcation and 
femoral artery ligature on the lesion side were preserved 
in liquid nitrogen. After homogenization using the liquid 
nitrogen grinding method, VCAM-I, ICAM-I, MCP-1 
and IGF-1 in injured vascular tissues were measured 
using an ELISA kit according to the manufacturer’s 
instructions. 
Statistical Analysis 
Data are expressed as mean ± SD. The statistical 
significance of inter-group differences was evaluated by 
one-way analysis of variance (one-way ANOVA) using 
software SPSS12.0 (SPSS Inc.). A value of P<0.05 was 
considered significant. 
RESULTS 
Histopathological Assessment 
Compared with the sham-operated group, hematoxylin-
eosin-stained histological sections from animals in the 
model group showed endothelial denudation and cell 
detachment from the femoral artery surface. Large 
amounts of lipid droplets and foam cells appeared under 
the common femoral artery and some lipid droplets even 
merged to form lipid pools. Based on this 
histopathological assessment, we concluded that the 
animal model could be considered to be in the advanced 
state of atherosclerosis. Treatment with Simvastatin and 
all doses of Shenlian Extracts improved these 
pathological changes to some extent (Figure 1). 
Blood Lipoprotein Measurement 
In the atherosclerosis model group, levels of serum 
cholesterol, triglyceride and low density lipoprotein were 
higher than those in other groups, but high density 
lipoprotein was significantly lower than in 
sham-operated rabbits fed with a regular diet. 
Pre-treatment with Simvastatin and graded doses of 
Shenlian Extracts caused significant reductions in the 
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serum levels of total cholesterol (90, 180 and 360 mg/kg) 
(P<0.05, P<0.05, P<0.05), triglyceride (180 and 360 
mg/kg) (P<0.05, P<0.01), and LDL-c (90 and 180 mg/kg) 
(P<0.05, P<0.05, Table 1). 
          
Figure 1. Hematoxylin-eosin-stained histological sections. I) An example of hematoxylin-eosin-stained sections of 
aortic segments from rabbits in the sham group; II) An example section of atherosclerosis model rabbits without any 
treatment; III) An example section of the rabbits treated with Simvastatin at 10 mg/kg/day; IV–VI) Example section of 
rabbits treated with Shenlian Extracts at 90 mg/kg/day, 180 mg/kg/day, and 360 mg/kg/day. Magnification × 200. 
Table 1. Effect of treatment with 10 mg/kg Simvastatin and 90-360 mg/kg Shenlian Extracts for 10 weeks on serum 
triglyceride, total cholesterol and LDL-c, HDL-c, in atherosclerotic rabbits 
Group Serum total cholesterol 
(mmol/L) 
Serum triglyceride 
(mmol/L) 
Serum HDL-c 
(mmol/L) 
Serum LDL-c 
(mmol/L) 
I  2.39±0.68 b   1.14±0.21 b  0.71±0.25 b   1.51±1.32 b 
II 15.15±3.63 3.10±1.08 0.44±0.07 12.39±4.36 
III 8.51±0.61a 1.65±0.79  0.73±0.17 b   4.32±1.03 b
IV 11.12±3.79a 2.21±1.32 0.42±0.04   6.12±1.11 a 
V 8.76±1.32a  1.12±0.55 a 0.47±0.03   8.31±4.34 a 
VI 11.13±4.39a  0.89±0.13 b 0.50±0.09  9.18±3.10 
Notes: a and b represent significant increases at P<0.05 and P<0.01, respectively, compared with Group II; I: treatment with distilled water 
10 mL/kg/day + sham operation + ordinary diet; II: pre-treatment with distilled water 10 ml/kg/day + endothelial injury + high fat diet; III: 
pre-treatment with Simvastatin 10 mg/kg/day + endothelial injury + high fat; IV: pre-treatment with Shenlian Extracts 90 mg/kg/day + 
endothelial injury + high fat; V: pre-treatment with Shenlian Extracts 180 mg/kg/day + endothelial injury + high fat; VI: pre-treatment with 
Shenlian Extracts 360 mg/kg/day + endothelial injury + high fat. 
Correlative Inflammatory Factors Measurement 
After 10 weeks, serum levels of TNF-Į, IL-8 and CRP 
were higher in the model group compared with the 
control group. Various doses of Shenlian Extracts 
reduced serum levels of TNF-Į (180 and 360 mg/kg) 
(P<0.01, P<0.01), CRP (90, 180 and 360 mg/kg) 
(P<0.01, P<0.01, P<0.05) and IL-8 (360 mg/kg) 
(P<0.05). Serum IL-1ȕ levels did not significantly 
change in any group (Table 2). 
The levels of ICAM-1, VCAM-1, MCP-1 and IGF-1 in 
vascular tissues increased sharply in the model group in 
the 10th week. Pre-treatment with Simvastatin or 
Shenlian Extracts significantly reduced VCAM-1 levels 
(90 and 360 mg/kg) (P<0.05, P<0.01) and IGF-1 levels 
(90 and 180 mg/kg) (P<0.01, P<0.01), but did not cause 
a significant effect on ICAM-1 and MCP-1 levels (Table 
3).  
Monocyte CD18 Measurement 
Expression of CD18 by peripheral blood monocytes 
increased sharply in animals of the model group in the 
10th week (P<0.01). Various doses of Shenlian Extracts 
significantly reduced this abnormal expression of CD18, 
in a dose-dependent manner (P<0.05, P<0.05, P<0.01). 
Western blots showed the same increase of CD18 in the 
model group (P<0.01). Each of the three doses of 
Shenlian Extracts inhibited CD18 expression 
significantly (P<0.05, P<0.01, P<0.01), while 
Simvastatin showed no such effect (Figure 2). 
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Table 2. Effect of treatment with 10 mg/kg Simvastatin and 90–360 mg/kg Shenlian Extracts for 10 weeks on serum 
TNF-Į, IL-1 ȕ, CRP, IL-8 in a rabit model of atherosclerosis
Group Serum TNFĮ (ng/mL) Serum CRP (ȝg/mL) Serum IL-1ȕ (ng/mL) Serum IL-8 (ng/mL) 
I  1.82±1.10 b  0.82±0.32 b 1.79±0.39  1.14±0.20 b 
II 4.10±1.69 3.24±0.36 2.00±0.89 1.87±0.46 
III  1.25±0.74 b  1.04±0.54 b 2.37±0.65  1.20±0.31 b 
IV 3.27±0.74  1.66±0.61 b 1.70±0.65 1.39±0.28 
V  1.69±0.29 b  1.27±0.16 b 2.12±0.87 1.57±0.23  
VI  1.62±0.28 b  2.11±1.35 a 2.82±0.89  1.01±0.31 a  
Notes: a and b represent significant increases at P<0.05 and P<0.01, respectively, compared with Group II. For group definitions, see Table 
1. 
Table 3. Effect of treatment with 10 mg/kg Simvastatin and 90-360 mg/kg Shenlian Extracts for 10 weeks on vascular 
tissue VCAM-I, ICAM-I, IGF-1,MCP-1 in a rabbit model of atherosclerosis 
Group Vascular tissue ICAM-1  
(ng/mg) 
Vascular tissue VCAM-1  
(ng/mg) 
Vascular tissue MCP-1 
(pg/mg)  
Vascular tissue IGF-1 
(ng/mg) 
I   28.70±7.33 b 16.68±5.14 b   90.35±11.46 a 25.01±7.37 b 
II  42.89±12.82 38.67±10.32 122.80±21.01 45.51±12.07 
III  38.45±12.97  23.41±11.45 b   92.41±26.45 a 26.41±8.16 b 
IV 41.32±4.13  25.48±12.62 a  113.87±10.54 25.82±9.28 b 
V 36.42±13.35 31.32±10.05 112.21±36.49 23.10±13.33 b 
VI 39.15±12.32 28.41±4.90 a  99.98±43.12  34.34±6.75 
Notes: a and b represent significant increases at P<0.05 and P<0.01, respectively, compared with Group II. For group definitions, Table 1. 
Figure 2. Effect of treatment with 10 mg/kg Simvastatin and 90–360 mg/kg Shenlian Extracts for 10 weeks on CD18 
expression in atherosclerotic rabbits. Ƹ and ƸƸ represent significant increases at P<0.05 and P<0.01, respectively, 
compared with Group II. For group definitions, see Table 1. 
DISCUSSION 
The injury-response theory and inflammatory reaction 
theory illustrate that atherosclerosis plaques form
gradually on vessel walls during a process of chronic 
inflammatory damage and body repair responses. The 
inflammatory response is one of the key aspects of 
atherosclerosis pathology, and anti-inflammatory 
interventions can block this inflammatory response, 
thereby postponing the process or lessening the damage 
in the early and middle stages of the disease. 
Anti-inflammatory treatment also greatly reduces the 
incidence of acute cardio-cerebral-vascular incidents in 
advanced-stage atherosclerosis. Thus, anti-inflammatory 
intervention is theoretically and practically valuable for 
the prevention and treatment of atherosclerosis. 
Traditional Chinese Medicine (TCM) has been practiced 
for thousands of years. In recent years, many Chinese 
medical specialists recognized from their clinical 
experiences that atherosclerosis was closely related to the 
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conditions endogenous heat toxin and the damage of 
brain collateral by toxins.13,14 At present, the methods of 
heat-clearing and detoxication, removing toxins and 
decreasing turbid pathogens, and detoxication and 
purgation15-17 have been widely used in Chinese 
medicine treatment of arteriosclerotic cardiovascular and 
cerebrovascular diseases. 
Medical research has found that the pathogenesis of 
atherosclerosis as endogenous heat toxin in Chinese 
medicine is very similar to the current mainstream 
theories of injury-response theory and inflammatory 
reaction theory. This similarity provides an interesting 
conjunction of the theories on atherosclerosis 
pathogenesis from both Chinese and Western medicine 
systems. In Chinese medicine, intervention in 
endogenous heat toxin or inflammatory response by 
activating blood circulation to dissipate blood stasis and 
heat-clearing and detoxication have been discussed as a 
method for the prevention and treatment of 
atherosclerosis.  
Based on this thinking, Shenlian Extracts is believed to 
have multiple therapeutic and preventive effects against 
human vascular diseases, including atherosclerosis. We 
previously found that Shenlian Extracts could inhibit 
atherosclerosis formation in rats by regulating lipid 
metabolism, inducing endothelial cells contraction and 
excretion, and improving hemorheology. In this study, 
we show that Shenlian Extracts significantly reduces the 
formation of atherosclerosis plaques. We suggest that the 
mechanism of the effects of Shenlian Extracts might be 
that it improves lipid metabolism, directly reduces lipid 
deposition and also indirectly inhibits lipid deposition via 
an anti-inflammatory. Shenlian Extracts might also 
inhibit the formation and abnormal release of 
inflammatory agents, reducing the concentration of 
proinflammatory cytokines, adhesion molecules, 
chemotactic factors and growth factors. Finally, it might 
also interrupt the abnormally high expression of CD18 in 
monocytes during atherosclerosis.  
In conclusion, our results suggest that Shenlian Extracts 
can inhibit the inflammatory reaction in initiation and 
development of atherosclerosis, and may therefore be 
used to treat atherosclerosis. This study highlights the 
promising possibility of atherosclerosis prevention by 
TCM based on activating blood circulation to dissipate 
blood stasis and heat-clearing and detoxication therapies. 
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